Information for Consumers
EMD Serono, Canada is committed to providing neutral and objective information about the products available on the market to consumers in Canada, to support them in understanding and managing their disease.
Federal regulations place restrictions on the provision of prescription drug information directly to consumers. Please note that we cannot provide healthcare recommendations or advice to patients. Your healthcare professional is the best source of information regarding your health.
If you have any questions regarding your therapy or require more detailed information, we recommend that you direct them to your physician, pharmacist, nurse or other qualified healthcare professional.
Herein you will find information about our marketed drugs. The information in these documents is part of the official product monographs approved by Health Canada and is intended only for residents of Canada.
- LUVERIS (Lutropin alpha)
- MAVENCLAD (cladribine tablets)
- OVIDREL (Choriogonadotropin alfa)
- PERGOVERIS (follitropin alfa/lutropin alfa (150 IU:75 IU))
- REBIF (Interferon beta 1a)